Page last updated: 2024-09-03

14-fluoro-6-thiaheptadecanoic acid and Cardiomyopathy, Congestive

14-fluoro-6-thiaheptadecanoic acid has been researched along with Cardiomyopathy, Congestive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Degrado, TR; Nickles, RJ; Russell, DC; Stanko, P; Stone, CK; Taylor, M; Wallhaus, TR1

Other Studies

1 other study(ies) available for 14-fluoro-6-thiaheptadecanoic acid and Cardiomyopathy, Congestive

ArticleYear
An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:1

    Topics: Cardiomyopathy, Dilated; Fatty Acids; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed

2001